Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01476449 · ClinicalTrials.gov registry record · Phase 2
Dosing Study of Ranibizumab for Diabetic Retinal and Macular Edema
A Phase 2 study of Diabetic Retinopathy and Macular Edema, sponsored by Retina Vitreous Associates of Florida.
- Completed
- Registry status
- Phase 2
- Development phase
- 20
- Enrollment target
- 2
- Study locations
NCT01476449 is a Phase 2 study of Diabetic Retinopathy and Macular Edema that has completed, run by Retina Vitreous Associates of Florida. The registered enrollment target is 20 participants, below the 1,676-participant average among 57 other Diabetic Retinopathy trials with a reported enrollment target (99% lower). The trial reports 2 study locations across 1 state.
The verdict
NCT01476449, a Phase 2 study of Diabetic Retinopathy and Macular Edema, has completed, sponsored by Retina Vitreous Associates of Florida.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 20 participants
- Enrollment target
- 2
- Study locations
Study Summary
This study is to see whether treating diabetic retinal swelling with ranibizumab injections into the eye monthly is better than treating diabetic retinal swelling with ranibizumab injections into the eye less frequently.
Conditions Studied
Interventions
- DRUG Ranibizumab
Study Locations (2)
Florida
- Retina Vitreous Associates of Florida - Clearwater
- Retina Vitreous Associates of Florida - St. Petersburg
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2011-11 |
| Est. Completion | 2016-09 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01476449
The ClinicalTrials.gov registry entry for NCT01476449 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,676-participant average among 57 other Diabetic Retinopathy trials with a reported enrollment target (99% lower). The listed sponsor is Retina Vitreous Associates of Florida, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Diabetic Retinopathy appearing as the primary indexed condition, and to 1 intervention - of which Ranibizumab is the first listed.
NCT01476449 reports 2 study locations spanning 1 distinct geographic area - top geographies include Florida.
Frequently Asked Questions
What is clinical trial NCT01476449 about?
NCT01476449 is a clinical study titled "Dosing Study of Ranibizumab for Diabetic Retinal and Macular Edema". This study is to see whether treating diabetic retinal swelling with ranibizumab injections into the eye monthly is better than treating diabetic retinal swelling with ranibizumab injections into the eye less frequently.
What is the current status of trial NCT01476449?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 20 participants. The study started on 2011-11. Estimated completion is 2016-09.
What conditions does trial NCT01476449 study?
This clinical trial studies the following conditions: Diabetic Retinopathy, Macular Edema.
What interventions are being tested in trial NCT01476449?
The interventions under investigation include: Ranibizumab (DRUG).
Who is sponsoring clinical trial NCT01476449?
This trial is sponsored by Retina Vitreous Associates of Florida, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01476449 being conducted?
This trial has 2 study locations across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabetic Retinopathy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Study to Test Whether BI 764524 Helps People With an Eye Condition Called Diabetic Retinopathy
RECRUITING · Phase 2
-
A Study to Evaluate the Efficacy and Safety of Orally Administered VX-01
RECRUITING · Phase 2
-
Sleep, Diabetic Retinopathy and Melatonin
RECRUITING · Phase 2
-
4D-150 in Patients With Diabetic Macular Edema
ACTIVE NOT RECRUITING · Phase 2
-
A Study of PER-001 in Participants With Diabetic Retinopathy
ACTIVE NOT RECRUITING · Phase 2
-
Efficacy Study of Lucentis in the Treatment of Diabetic Macular Edema
COMPLETED · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.